| SC 13G/A | 2024-02-14 | Logos Global Management LP | Allakos Inc. | 2,900,000 | 3.3% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Allakos Inc. | - | 3.4% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Allakos Inc. | 2,510,736 | 2.9% | EDGAR |
| SC 13G/A | 2024-02-12 | PRICE T ROWE ASSOCIATES INC /MD/ | Allakos Inc. | 638,102 | 0.7% | EDGAR |
| SC 13G | 2024-02-12 | PRICE T ROWE ASSOCIATES INC /MD/ | Allakos Inc. | 7,920,708 | 9.1% | EDGAR |
| SC 13D/A | 2024-02-02 | RiverVest Venture Fund III, L.P. | Allakos Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2024-01-29 | BlackRock Inc. | Allakos Inc. | 5,116,088 | 5.8% | EDGAR |
| SC 13G/A | 2024-01-26 | Deep Track Capital, LP | Allakos Inc. | 2,510,736 | 2.9% | EDGAR |
| SC 13G | 2024-01-26 | Deep Track Capital, LP | Allakos Inc. | 5,000,000 | 5.7% | EDGAR |
| SC 13G/A | 2024-01-18 | BIOTECHNOLOGY VALUE FUND L P | Allakos Inc. | 4,558,983 | 5.2% | EDGAR |
| SC 13G/A | 2024-01-18 | BIOTECHNOLOGY VALUE FUND L P | Allakos Inc. | 8,679,726 | 9.9% | EDGAR |
| SC 13G | 2023-10-13 | CITADEL ADVISORS LLC | Allakos Inc. | - | 4.9% | EDGAR |
| SC 13D/A | 2023-08-18 | Alta Partners VIII, L.P. | Allakos Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-04-17 | Frazier Life Sciences Public Fund, L.P. | Allakos Inc. | 316,953 | 0.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Logos Global Management LP | Allakos Inc. | 5,286,666 | 6.2% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Allakos Inc. | 4,899,179 | 5.8% | EDGAR |
| SC 13G/A | 2023-02-14 | Frazier Life Sciences Public Fund, L.P. | Allakos Inc. | 3,871,936 | 4.5% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Allakos Inc. | 2,952,522 | 3.5% | EDGAR |
| SC 13G/A | 2023-01-10 | MILLENNIUM MANAGEMENT LLC | Allakos Inc. | 834,610 | 1.0% | EDGAR |
| SC 13D | 2022-10-11 | New Enterprise Associates 16, L.P. | Allakos Inc. | 6,147,260 | 7.3% | EDGAR |